Global Cancer Profiling Market is expected to grow at a CAGR of 15.67% to reach US$49.176 billion by 2027, from US$17.750 billion in 2020.
The quickly rising field of customized medication, along with the rising spotlight on biomarker research for drug advancement, makes sense of the significant extent of the cancer profiling market.
